Eukaryotic RNA Polymerase I

Eukaryotic RNA polymerase I (RNAP I) is an enzyme responsible for transcribing ribosomal RNA (not 5S rRNA), which accounts for over 50% of total RNA in a cell. Here is the latest research.

May 28, 2020
Review

Evolution and Adaptation of the Avian H7N9 Virus into the Human Host

Microorganisms
Andrew T Bisset, Gerard F Hoyne
September 2, 2020
Preprint
Open Access

Comparative study of a 3CL pro inhibitor and remdesivir against both major SARS-CoV-2 clades in human airway models

BioRxiv : the Preprint Server for Biology
Maren de VriesMeike Dittmann
June 11, 2020
Review
Open Access

Myc as a Regulator of Ribosome Biogenesis and Cell Competition: A Link to Cancer

International Journal of Molecular Sciences
Francesca DestefanisPaola Bellosta
July 24, 2020
Open Access

GTP Metabolic Reprogramming by IMPDH2: Unlocking Cancer Cells' Fueling Mechanism

Journal of Biochemistry
Satoshi Kofuji, Atsuo T Sasaki
July 4, 2020
Open Access

Genome-wide analyses of chromatin interactions after the loss of Pol I, Pol II, and Pol III

Genome Biology
Yongpeng JiangXiong Ji
July 18, 2020
Open Access

A small targeting domain in Ty1 integrase is sufficient to direct retrotransposon integration upstream of tRNA genes

The EMBO Journal
Amna Asif-LaidinPascale Lesage
September 19, 2020
Open Access

Reprogrammed mRNA translation drives resistance to therapeutic targeting of ribosome biogenesis

The EMBO Journal
Eric P KusnadiRichard B Pearson
September 18, 2020
Open Access

Biophysical and dynamic characterization of a fine-tuned binding of the human Respiratory Syncytial Virus M2-1 core domain to long RNAs

Journal of Virology
I. P. CarusoFátima P Souza
September 12, 2020

Dynamics of the RNA polymerase I TFIIF/TFIIE-like subcomplex: a mini-review

Biochemical Society Transactions
Bruce A KnutsonLawrence I Rothblum
June 20, 2020
Review

A Comprehensive View of Translesion Synthesis in Escherichia coli

Microbiology and Molecular Biology Reviews : MMBR
Shingo Fujii, Robert P Fuchs
September 24, 2020
Preprint

Therapeutic Targeting of Measles Virus Polymerase with ERDRP-0519Suppresses All RNA Synthesis Activity

BioRxiv : the Preprint Server for Biology
R. CoxRichard K. Plemper
July 17, 2020
Open Access

Nucleolar RNA polymerase II drives ribosome biogenesis

Nature
Karan J AbrahamKarim Mekhail

Sign up to follow this feed and discover related papers.

Related Feeds

Alternative splicing

Alternative splicing a regulated gene expression process that allows a single genetic sequence to code for multiple proteins. Here is that latest research.

Archaeal RNA Polymerase

Archaeal RNA polymerases are most similar to eukaryotic RNA polymerase II but require the support of only two archaeal general transcription factors, TBP (TATA-box binding protein) and TFB (archaeal homologue of the eukaryotic general transcription factor TFIIB) to initiate basal transcription. Here is the latest research on archaeal RNA polymerases.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

CRISPR & Single Cell Analyses

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on CRISPR-Cas applications relevant to single cell analyses. Here is the latest research.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

CRISPR Genome Editing & Therapy

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of this system for gene editing and therapy in human diseases.

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

CRISPR Screens in Virology

This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that affect virus-host interactions. Here is the latest research.

© 2020 Meta ULC. All rights reserved
/feed-previews/eukaryotic-rna-polymerase-i/b34e21d5-d0ad-402d-9a4f-fee4e82cdb68